Ambev SA
ABEV
3.15
-0.07
-2.17%
Ambev SA
US · ABEV
#486 by market cap
Listed 1970
3.15
-0.07
-2.17%
Live - 5344 symbols - heartbeat 63s ago
· 2026-10-08 04:42
Pre-market
3.20
+1.59%
After-hours
3.15
0.00%
Overnight
3.20
+1.59%
- Market cap
- 48.56B
- P/E (TTM)i
- 15.22
- P/Bi
- 2.76
- EPSi
- 0.20
- Div yieldi
- 4.89%
- 52W posi
- 81%
Reader sentiment
Are you bullish or bearish on ABEV?
Anonymous reader poll. Unscientific, not investment advice.
Revenue annual, last 8 years
Latest year -1.35% YoY
Margins
- Gross margin
- 51.42%
- Operating margin
- 25.30%
- Net margin
- 17.57%
Key ratios & quality
- Enterprise valuei
- 29.67B
- PEG ratioi
- 6.46
PEG uses trailing P/E against the 3-year net income growth rate (2.35%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG."
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 50.23B | 52.01B | 58.38B | 72.85B | 79.71B | 79.74B | 89.45B | 88.24B |
| Gross profit | 30.98B | 30.33B | 31.31B | 37.19B | 39.29B | 40.45B | 45.84B | 45.38B |
| Selling & admin expenses | 14.69B | 15.33B | 17.57B | 21.85B | 23.97B | 23.44B | 26.39B | 25.14B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 16.93B | 16.24B | 16.06B | 17.19B | 17.40B | 18.77B | 21.51B | 22.32B |
| Pretax profit | 13.12B | 12.94B | 13.49B | 13.76B | 14.24B | 15.04B | 19.49B | 19.42B |
| Tax | 1.77B | 754.70M | 1.76B | 636.60M | -655.60M | 75.50M | 4.64B | 3.43B |
| Net profit | 11.35B | 12.19B | 11.73B | 13.12B | 14.89B | 14.96B | 14.85B | 15.99B |
| Basic EPS | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Diluted EPS | 0.69 | 0.74 | 0.72 | 0.80 | 0.91 | 0.92 | 0.91 | 0.99 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 22.50B | 20.09B | 20.85B | 24.81B | 22.46B | 20.15B |
| Gross profit | 11.55B | 10.04B | 10.73B | 13.06B | 11.58B | 10.45B |
| Selling & admin expenses | 6.44B | 6.18B | 5.83B | 6.69B | 6.23B | 6.37B |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 5.63B | 4.37B | 5.27B | 7.39B | 5.87B | 4.76B |
| Pretax profit | 4.86B | 3.42B | 5.21B | 5.93B | 4.93B | 4.34B |
| Tax | 1.05B | 629.11M | 350.17M | 1.40B | 1.05B | 864.50M |
| Net profit | 3.80B | 2.79B | 4.86B | 4.53B | 3.89B | 3.47B |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.23 | 0.17 | 0.30 | 0.28 | 0.24 | 0.22 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 25.33B | 27.62B | 35.34B | 38.63B | 37.82B | 36.56B | 54.16B | 43.88B |
| Cash & ST investments | 11.48B | 11.92B | 18.79B | 18.54B | 15.38B | 16.34B | 29.84B | 20.32B |
| Inventory | 5.10B | 5.65B | 7.22B | 10.35B | 12.56B | 9.08B | 11.69B | 10.52B |
| Total assets | 95.71B | 101.74B | 125.20B | 138.60B | 137.96B | 132.64B | 162.51B | 145.09B |
| Total current liabilities | 25.21B | 25.01B | 33.48B | 38.87B | 40.54B | 41.01B | 49.39B | 45.60B |
| Short-term debt | 1.94B | 653.10M | 2.74B | 877.60M | 1.06B | 1.30B | 1.28B | 1.17B |
| Long-term debt | 850.70M | 697.80M | 338.40M | 267.20M | 454.30M | 391.00M | 324.00M | 256.90M |
| Total liabilities | 38,259,500,000.00 | 39,186,900,000.00 | 50,045,100,000.00 | 54,584,900,000.00 | 54,630,200,000.00 | 52,500,500,000.00 | 62,927,800,000.00 | 56,312,400,000.00 |
| Total equity | 57.45B | 62.56B | 75.15B | 84.02B | 83.33B | 80.14B | 99.58B | 88.77B |
| Retained earnings | 0 | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 43.55B | 40.79B | 41.94B | 43.88B | 42.83B | 40.47B |
| Cash & ST investments | 20.31B | 17.52B | 19.84B | 20.32B | 19.64B | 18.35B |
| Inventory | 11.55B | 11.35B | 10.47B | 10.52B | 10.40B | 10.42B |
| Total assets | 147.30B | 142.16B | 140.75B | 145.09B | 142.76B | 138.21B |
| Total current liabilities | 39.34B | 36.87B | 36.58B | 45.60B | 41.66B | 39.62B |
| Short-term debt | 1.12B | 1.10B | 1.05B | 1.17B | 1.10B | 1.07B |
| Long-term debt | 284.78M | 299.23M | 264.07M | 256.90M | 234.23M | 1.88B |
| Total liabilities | 51,823,085,000.00 | 48,946,586,000.00 | 48,026,583,000.00 | 56,312,400,000.00 | 51,937,254,000.00 | 49,315,800,000.00 |
| Total equity | 95.48B | 93.21B | 92.73B | 88.77B | 90.82B | 88.89B |
| Retained earnings | 2.99B | 4.32B | 7.43B | -- | 4.31B | 7.52B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 18.35B | 18.38B | 18.86B | 22.90B | 20.64B | 24.71B | 26.10B | 24.45B |
| Depreciation & amortization | 4.45B | 4.68B | 5.17B | 5.40B | 5.96B | 6.42B | 7.13B | 6.83B |
| Free cash flow | 14.78B | 13.31B | 14.16B | 15.22B | 14.11B | 18.71B | 21.35B | 19.86B |
| Dividends paid | -8.81B | -7.87B | -6.85B | -11.12B | -12.24B | -11.92B | -4.06B | -20.46B |
| Stock buybacks / issuance | 13.50M | -32.10M | -7.40M | -35.10M | -30.30M | -104.50M | -450.10M | -1.93B |
| Ending cash balance | 11.46B | 11.90B | 17.09B | 16.60B | 14.85B | 16.06B | 28.60B | 18.64B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 1.20B | 3.05B | 6.92B | 13.25B | 3.16B | 4.71B |
| Depreciation & amortization | 1.71B | 1.70B | 1.60B | 1.82B | 1.60B | 1.53B |
| Free cash flow | 375.82M | 1.96B | 5.88B | 11.62B | 2.69B | 3.83B |
| Dividends paid | -6.61B | -2.08B | -2.08B | -9.69B | -1.52M | -1.18B |
| Stock buybacks / issuance | -1.03B | -774.60M | 27.00K | -90.87M | -398.60M | -2.28B |
| Ending cash balance | 19.12B | 16.40B | 18.31B | 18.64B | 17.99B | 16.61B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 21.54 | 20.03 | 16.85 | 16.20 | 17.57 | 18.02 | 16.26 | 16.62 |
| ROA %i | 12.18 | 12.03 | 10.03 | 9.61 | 10.46 | 10.72 | 9.78 | 10.08 |
| ROIC %i | 22.27 | 20.30 | 15.75 | 16.22 | 17.38 | 17.96 | 16.28 | 17.15 |
| 5-year avg ROE %i | 24.07 | 22.42 | 20.30 | 18.15 | 18.45 | 17.74 | 16.98 | 16.93 |
| EBIT margin %i | 29.25 | 28.08 | 26.73 | 21.41 | 21.49 | 22.39 | 24.47 | 25.09 |
| FCF / sales %i | 28.55 | 25.31 | 24.26 | 20.90 | 17.70 | 23.46 | 23.87 | 22.51 |
| Current ratioi | 1.00 | 1.10 | 1.06 | 0.99 | 0.93 | 0.89 | 1.10 | 0.96 |
| Quick ratioi | 0.73 | 0.82 | 0.79 | 0.67 | 0.58 | 0.62 | 0.80 | 0.66 |
| Debt / assetsi | 4.29 | 3.01 | 3.83 | 2.26 | 2.79 | 2.64 | 2.12 | 2.33 |
| LT debt / equityi | 3.84 | 3.93 | 2.78 | 2.73 | 3.40 | 2.79 | 2.21 | 2.52 |
| Interest coveragei | 9.64 | 8.09 | 7.39 | 8.49 | 5.92 | 6.34 | 9.13 | 8.14 |
| Revenue CAGR (3Y) %i | 2.44 | 4.48 | 6.82 | 13.19 | 15.30 | 10.95 | 7.08 | 3.45 |
| Net income CAGR (3Y) %i | -3.99 | -2.08 | 16.11 | 4.84 | 7.07 | 8.42 | 4.45 | 2.35 |
| FCF CAGR (3Y) %i | -6.92 | 17.47 | -2.02 | 1.00 | 1.96 | 9.72 | 11.93 | 12.07 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 15.93 | 15.72 | 16.87 | 16.62 | 16.87 | 17.97 |
| ROA %i | 10.27 | 10.33 | 11.14 | 10.08 | 10.74 | 11.59 |
| ROIC %i | 15.94 | 15.87 | 17.17 | 17.15 | 17.47 | 17.94 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 24.25 | 24.22 | 25.31 | 25.09 | 25.22 | 26.12 |
| FCF / sales %i | 24.02 | 23.61 | 22.81 | 22.51 | 25.14 | 27.24 |
| Current ratioi | 1.11 | 1.11 | 1.15 | 0.96 | 1.03 | 1.02 |
| Quick ratioi | 0.74 | 0.71 | 0.79 | 0.66 | 0.68 | 0.67 |
| Debt / assetsi | 2.18 | 2.22 | 2.06 | 2.33 | 2.18 | 2.13 |
| LT debt / equityi | 2.22 | 2.22 | 2.01 | 2.52 | 2.22 | 2.12 |
| Interest coveragei | 9.40 | 9.42 | 9.16 | 8.14 | 8.09 | 8.73 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-10-08 04:42:36 · For reference only, not investment advice and not tailored to your situation.